Are we ready to take full advantage of patient‐derived tumor xenograft models?

Publisher: John Wiley & Sons Inc

E-ISSN: 1099-1069|36|1|24-27

ISSN: 0278-0232

Source: Hematological Oncology (Electronic), Vol.36, Iss.1, 2018-02, pp. : 24-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next